| Primary |
| Pneumonia |
16.2% |
| Infection |
13.0% |
| Pyrexia |
9.1% |
| Lung Infection |
7.5% |
| Cholangitis |
7.1% |
| Prophylaxis |
5.5% |
| Infection Prophylaxis |
5.1% |
| Hypertension |
4.3% |
| Arthritis Infective |
4.0% |
| Sepsis |
4.0% |
| Bacterial Sepsis |
3.6% |
| B-cell Lymphoma |
3.2% |
| Cholecystitis |
3.2% |
| Antiinflammatory Therapy |
2.4% |
| Bronchitis |
2.4% |
| Pneumonia Aspiration |
2.4% |
| Acinetobacter Infection |
2.0% |
| Pancreatitis |
2.0% |
| Chemotherapy |
1.6% |
| Delirium |
1.6% |
|
| Platelet Count Decreased |
15.3% |
| Anaphylactic Shock |
13.1% |
| Shock |
11.9% |
| White Blood Cell Count Decreased |
6.8% |
| Death |
4.5% |
| Pseudomembranous Colitis |
4.5% |
| Renal Failure Acute |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Convulsion |
4.0% |
| Pancytopenia |
4.0% |
| Vomiting |
4.0% |
| Hypersensitivity |
3.4% |
| Adverse Event |
2.8% |
| Thrombocytopenia |
2.8% |
| Agranulocytosis |
2.3% |
| Cholestasis |
2.3% |
| Coagulation Test Abnormal |
2.3% |
| Coagulopathy |
2.3% |
| Hepatitis Fulminant |
2.3% |
| Hypoprothrombinaemia |
2.3% |
|
| Secondary |
| Pneumonia |
26.7% |
| Hypertension |
13.3% |
| Pyrexia |
9.2% |
| Anaesthesia |
8.2% |
| Prophylaxis |
5.1% |
| Cholecystitis |
4.1% |
| Gastritis |
4.1% |
| Drug Use For Unknown Indication |
3.6% |
| Pneumonia Aspiration |
3.6% |
| Gastric Haemorrhage |
3.1% |
| Hepatic Cirrhosis |
3.1% |
| Cholangitis |
2.1% |
| Post Procedural Infection |
2.1% |
| Urinary Retention |
2.1% |
| Urinary Tract Infection |
2.1% |
| Biliary Tract Infection |
1.5% |
| Bronchitis |
1.5% |
| Candidiasis |
1.5% |
| Hypertonic Bladder |
1.5% |
| Infection |
1.5% |
|
| Vomiting |
17.7% |
| Stevens-johnson Syndrome |
14.5% |
| Platelet Count Decreased |
9.7% |
| Toxic Epidermal Necrolysis |
9.7% |
| Nausea |
4.8% |
| Renal Failure Chronic |
4.8% |
| Erythema |
3.2% |
| Hepatitis Fulminant |
3.2% |
| Multi-organ Failure |
3.2% |
| Oesophageal Varices Haemorrhage |
3.2% |
| Penis Disorder |
3.2% |
| Respiratory Failure |
3.2% |
| Shock |
3.2% |
| Staphylococcal Infection |
3.2% |
| Toxic Skin Eruption |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Anaphylactic Reaction |
1.6% |
| Anaphylactic Shock |
1.6% |
| Blood Bilirubin Increased |
1.6% |
| Death |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.7% |
| Pneumonia |
11.4% |
| Hypertension |
7.7% |
| Prophylaxis |
7.2% |
| Aplastic Anaemia |
6.2% |
| Product Used For Unknown Indication |
5.5% |
| Pyrexia |
5.4% |
| Malaise |
5.1% |
| Renal Transplant |
4.5% |
| Diabetes Mellitus |
3.4% |
| Infection |
3.2% |
| Premedication |
3.2% |
| Colon Cancer |
2.9% |
| Liver Transplant |
2.9% |
| Angina Pectoris |
2.8% |
| Cardiac Failure |
2.7% |
| Liver Disorder |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Cardiac Failure Congestive |
2.4% |
| Neoplasm Malignant |
2.4% |
|
| White Blood Cell Count Decreased |
11.8% |
| Rash |
8.8% |
| Sepsis |
8.8% |
| Respiratory Failure |
7.4% |
| Meningitis Listeria |
5.9% |
| White Blood Cell Count Increased |
5.9% |
| Death |
5.1% |
| Renal Failure |
4.4% |
| Thrombocytopenia |
4.4% |
| Renal Impairment |
3.7% |
| Septic Shock |
3.7% |
| Somnolence |
3.7% |
| Superinfection |
3.7% |
| Ventricular Fibrillation |
3.7% |
| Viral Infection |
3.7% |
| Vomiting |
3.7% |
| Hepatic Function Abnormal |
2.9% |
| Hepatitis Fulminant |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Meningitis |
2.9% |
|
